Active clinical trials
Dry / Atrophic AMD
Trial for the treatment of Atrophic Macular Degeneration
- Duration: 18 months
- Impact: International
- Treatment: Gene therapy
- Cost for the patient: €0
- Travel expenses: Covered
Open recruitment
Study for the treatment of dry AMD with loss of photoreceptors
- Phase 3
- Duration: 2 years
- Impact: International
- Treatment: Mitochondrial protection agent
- Cost for the patient: €0
- Travel expenses: Covered
Study activation planned for September/October 2024
Study to evaluate conjunctiva and Tenon's capsule in healthy subjects and patients with wet AMD and/or diabetic macular edema
- Duration: Single visit
- Impact: National
- Treatment: Ophthalmological examination
- Cost for the patient: €0
Study activation planned for October/November 2024
Dry Eye
Study on the treatment of Moderate and Severe Dry Eye related to meibomian gland dysfunction
- Duration: 3 months
- Impact: International
- Treatment: Topical eye formula (drops)
- Cost for the patient: €0
- Travel expenses: Covered
Open recruitment
Trial for the treatment of moderate/severe dry eye
- Duration: 36 days (4 visits)
- Impact: International
- Treatment: Topical eye formula (drops)
- Cost for the patient: €0
- Travel expenses: Covered
Open recruitment
Neurotrophic Keratopathy
Study on the treatment of Neurotrophic Keratopathy.
- Duration: 6 weeks Impact
- Impact: International
- Treatment: Ophthalmic solution (eye drops)
- Cost for the patient: €0
- Travel expenses: Covered
Open recruitment
Intracorneal Rings
Prospective study to assess the clinical outcome of the Intrastromal Corneal Ring implanted in patients with Keratoconus.
- Duration: 3 years
- Impact: International
- Treatment: Corneal ring implanted using femtosecond laser
- Cost of lenses for the patient: €0
- Travel expenses: Covered
Open recruitment
Intraocular Lenses
Prospective study to assess the clinical outcome of Toric Phakic Intraocular Lens implantation in patients with Moderate/High Myopia with Astigmatism.
- Duration: 3 years
- Impact: International
- Treatment: Implantation of toric phakic intraocular lens
- Cost of lenses for the patient: €0
- Travel expenses: Covered
Study activation scheduled for early 2025
Prospective post-market study to evaluate the performance of Phakic Lens in patients with Myopia.
- Duration: 3 years
- Impact: International
- Treatment: Implantation of intraocular phakic lens patients with myopia
- Cost of lenses for the patient: €0
- Travel expenses: Covered
Study activation scheduled for the end of 2024.
Prospective study to compare outcomes of two Trifocal Toric Lenses in patients with Cataracts and coexisting Astigmatism who wish to be treated for presbyopia.
- Duration: 3 years
- Impact: International
- Treatment: Implantation of trifocal phakic intraocular lens
- Cost of lenses for the patient: €0
- Travel expenses: Covered
Study activation scheduled for 2025.
Study to evaluate the performance of intraocular lenses in patients with cataracts
- Duration: 2 years
- Impact: International
- Treatment: Implantation of a monofocal intraocular lens for patients with cataracts
- Cost of lenses for the patient: €0
- Travel expenses: Covered
Open recruitment
Geographic Atrophies
Study to evaluate geographic atrophy in comparison with healthy eyes
- Duration: 1 and a half year
- Impact: International
- Prospective non-interventional study
- Cost for the patient: €0
- Travel expenses: Covered
Open recruitment
Blepharospasm
- Phase 2
- Duration: 9 months
- Impact: International
- Treatment: modified recombinant botulinum neurotoxin serotype
- Cost for the patient: €0
- Travel expenses: Covered
Study activation planned for end of 2024
Application form
Please complete the form and select the clinical study that interests you the most. After receiving your application, we will contact you to start the participation process.